Cardiovascular Biomarkers

Novel Possible Biomarkers for the Cardiovascular Diseases Prognosis

Cardiovascular disease (CVD), especially heart failure (HF) as its common final pathway, is the leading cause of morbidity and mortality worldwide. Furthermore, oxidative and inflammatory processes represent fundamental underlying mechanisms for the development and progression of HF. Of interest, in recent years the development of markers with diagnostic and prognostic value for this pathology ...

Biomarkers in cardiovascular medicine.

Cardiovascular disease is the principal cause of death in developed countries. The underlying pathological process is arterial wall thickening due to the formation of atherosclerotic plaque, which is frequently complicated by thrombus, thereby giving rise to the possibility of acute coronary syndrome or stroke. One of the major challenges in cardiovascular medicine is to find a way of predictin...

Biomarkers of Cardiovascular Disease

Biomarkers, Obesity, and Cardiovascular Diseases

Obesity and overweight are among the major health problems in the world today. The excessive accumulation of fat in adipose tissue is accompanied by low‐grade inflamma‐ tion, adipokine secretion dysregulation, oxidative stress, and an alteration of the secretion of gut hormones and food intake related to peptides. This is related to the development of cardiovascular diseases, which have been in...

Cardiovascular biomarkers in diabetic nephropathy